ALFREDO
FERNÁNDEZ QUINTELA
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (4)
2021
-
Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: A comparison with its analog resveratrol
Food and Function, Vol. 12, Núm. 7, pp. 3266-3279
2019
-
Pterostilbene reduces liver steatosis and modifies hepatic fatty acid profile in obese rats
Nutrients, Vol. 11, Núm. 5
2013
-
Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats
Nutrition, Vol. 29, Núm. 11-12, pp. 1374-1380
2012
-
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
British Journal of Nutrition, Vol. 107, Núm. 2, pp. 202-210